Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142724 |
| CAS No | NA |
| Mol.F. | C24H16Cl2N4O2 |
| Mol.Wt. | 463.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142725 |
| CAS No | NA |
| Mol.F. | C12H8N4O |
| Mol.Wt. | 224.22 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142726 |
| CAS No | NA |
| Mol.F. | C21H23N3O9 |
| Mol.Wt. | 463.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142727 |
| CAS No | NA |
| Mol.F. | C24H21N3O7 |
| Mol.Wt. | 463.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142728 |
| CAS No | NA |
| Mol.F. | C18H19N3O8 |
| Mol.Wt. | 405.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142729 |
| CAS No | NA |
| Mol.F. | C27H29N3O8 |
| Mol.Wt. | 523.54 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142730 |
| CAS No | NA |
| Mol.F. | C27H27N3O8 |
| Mol.Wt. | 521.53 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142731 |
| CAS No | NA |
| Mol.F. | C16H11ClN4O5 |
| Mol.Wt. | 374.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142732 |
| CAS No | NA |
| Mol.F. | C15H11ClN4O2 |
| Mol.Wt. | 314.73 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142733 |
| CAS No | NA |
| Mol.F. | C15H9Cl2N3O5 |
| Mol.Wt. | 382.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142734 |
| CAS No | NA |
| Mol.F. | C15H9ClN4O4 |
| Mol.Wt. | 344.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142735 |
| CAS No | NA |
| Mol.F. | C13H7ClN4O3 |
| Mol.Wt. | 302.67 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142736 |
| CAS No | NA |
| Mol.F. | C20H11Cl2N3O5 |
| Mol.Wt. | 444.22 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142737 |
| CAS No | NA |
| Mol.F. | C15H9BrClN3O5 |
| Mol.Wt. | 426.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142738 |
| CAS No | NA |
| Mol.F. | C23H13ClN4O7 |
| Mol.Wt. | 492.83 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142739 |
| CAS No | NA |
| Mol.F. | C15H9BrClN3O5 |
| Mol.Wt. | 426.61g/mol |
| INV STATUS | CUSTOM SYNTHESIS |